ArticleCureus2025
Tuberculous Spondylodiscitis in South East Tunisia: Features and Predictive Factors of Poor Prognosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculous spondylodiscitis is a severe form of tuberculosis (TB) infection. The study aims to determine clinical and radiological features and treatment outcomes of tuberculous spondylodiscitis in southeast Tunisia and to identify factors associated with poor prognosis.
methodsA retrospective, single-center study was conducted over a period of 16 years (2008-2023). All patients treated for tuberculous spondylodiscitis were included. Data were collected on demographic, clinical, and radiological features, as well as treatment regimens and outcomes. Multivariable logistic regression analysis was performed to identify factors independently associated with unfavorable outcomes.
resultsTwenty-six patients were included in our study, with an average age of 46 years ± 15.69. A female predominance was observed (18 women and eight men). The average symptom duration was 5.6 months ± 4.35. Spinal pain was the revealing functional sign (80.7%). The diagnosis of TB was confirmed in 65.% of patients. Anti-TB treatment was prescribed in all patients with a mean duration of 13.88 ± 3.789 months (10-18 months). At one-month follow-up, 69.2% of patients had a favorable outcome. Independent predictors of poor prognosis included age ≥ 65 years (odds ratio (OR): 2.26), diagnostic delay ≥ 5 months (OR: 1.33), presence of spinal cord compression (OR: 13.9), and initial C-reactive protein (CRP) level ≥ 50 mg/L (OR: 1.24).
conclusionIn patients with tuberculous spondylodiscitis, the outcome at one month of follow-up was favorable in only 69.2%. Advanced age, delayed diagnosis (≥5 months), spinal cord compression, and elevated CRP levels (≥50 mg/L) emerged as independent predictors of poor outcomes at one-month follow-up. Further studies are required, particularly in TB-endemic countries, to investigate other factors associated with unfavorable outcomes of tuberculous spondylodiscitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.